Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

At-Home Genetic Testing: Dispelling Fact vs Fiction

February 14th 2019

This week, we spoke with FORCE to dispel some of the misconceptions associated with at-home genetic testing for hereditary cancer risk.

Targeting Ovarian Cancer

February 2nd 2019

Researchers are evaluating the use of folate receptors to treat platinum-resistant ovarian cancer.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

January 25th 2019

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

Alert: Cancer Genetic Testing Should Be Performed in the Health Care Setting

January 22nd 2019

There is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. If these promotions have caught your attention and you are considering testing, there is important information that you should know first.

Alisertib-Based Combo Improves Survival Outcomes in Ovarian, Breast Cancer

January 18th 2019

The addition of the investigational drug alisertib to a paclitaxel regimen showed promising activity in patients with recurrent ovarian cancer or advanced breast cancer.

Survey Highlights How 'Much More There Is to a Cancer Diagnosis'

January 17th 2019

A recent survey demonstrated the common tradeoffs most patients report regarding treatment decisions, highlighting the importance of shared decision making.

Cancerversary Prompts Top 10 List of Lessons Learned

January 9th 2019

Rather than revisiting the ghosts of cancer treatments past, I’m focused on using what I’ve learned in three years of active treatment and maintenance for incurable, metastatic cancer.

FDA Approves Lynparza for Maintenance Treatment of BRCA-Mutant Gynecologic Cancers

December 20th 2018

This is the first approval of a PARP inhibitor as a first-line maintenance treatment for BRCA-mutant gynecologic cancers.

FDA Approves Diagnostic Tool for BRCA-Mutant Ovarian Cancer

December 19th 2018

The Food and Drug Administration (FDA) approved BRACAnalysis CDx to be used to identify patients with advanced ovarian cancer who have germline BRCA mutations and are eligible for first line treatment with Lynparza (olaparib) after responding to platinum-based chemotherapy.

Overcoming the Psychological Effects of Ovarian Cancer

December 4th 2018

A new program offers counseling, patient education and vetted referrals to patients and their families.

Lynparza Significantly Delays Progression in Advanced Ovarian Cancer, Study Finds

December 4th 2018

Maintenance treatment with Lynparza (olaparib) after chemotherapy has been found to significantly extend progression-free survival in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation, according to a recent phase 3 study.

Learning the Lingo of Cancer

December 4th 2018

A cancer diagnosis can lead to discussions about family health history, as well as a whole new world to learn about.

Focusing on Quality of Life, Improving Outcomes in Ovarian Cancer

November 27th 2018

Patients with ovarian cancer are living longer than ever.

Legislation Seeks Medicare Recognition of Genetic Counselors to Expand Access to Care

November 26th 2018

To receive payment for counseling and increase access to services, a new bill has been introduced so that genetic counselors receive payment for counseling Medicare beneficiaries.

Giving Teeth to Oral Care

November 17th 2018

Certain cancer treatments can affect the mouth, so dental health should be a lifelong commitment.

FDA Grants Lynparza Priority Review for Frontline Maintenance in Ovarian Cancer

November 12th 2018

The FDA has granted a priority review designation to a supplemental new drug application (sNDA) for Lynparza (olaparib) tablets for use as a maintenance therapy in patients with newly-diagnosed, BRCA-positive advanced ovarian cancer who achieved a complete or partial response to standard frontline platinum-based chemotherapy.

Starting a Conversation

November 11th 2018

Families with certain genetic mutations face many complex and personal choices, including how and when to share such information with their children. Mom's Genes is here to help.

When Your Partner Has Cancer, It May Feel Like You Do Too

November 2nd 2018

Here are some tips on coping with the disease that seems to affect us all.

CURE's Top 5 Stories: October 2018

November 1st 2018

Here are the top 5 CURE stories for October 2018.

Maintenance Lynparza Improves PFS for Ovarian Cancer

October 30th 2018

The PARP inhibitor Lynparza (olaparib) significantly improved progression-free survival (PFS) as frontline maintenance therapy for women with BRCA-positive advanced ovarian cancer, according to findings from the randomized phase 3 SOLO-1 trial presented at the 2018 ESMO Congress.

Cobie Smulders: Not on My Watch

October 25th 2018

Actress partners with TESARO to launch national movement to help empower the ovarian cancer community

Joining Forces Against Hereditary Risk for Breast and Ovarian Cancer

October 24th 2018

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

Discussing Hereditary Cancer Risk With Children

October 22nd 2018

Although there is never the perfect time to have a risk-related discussion with a child, one clinical psychologist explains ways in which parents can approach the difficult topic.

Managing Lymphedema: Education is the Best Treatment

October 22nd 2018

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

It's All in the Family: Discussing Cancer Risk with Extended Family Members

October 20th 2018

One family shares their experience with the discovery of a BRCA mutation, and how they discussed it among one another.

Clinical Trial Participation is Key for Hereditary Cancer Research Advancement

October 20th 2018

Although individuals may have concerns about enrolling in a study, their involvement may lead to new discoveries.

One Previvor's Journey With a BRCA Mutation

October 19th 2018

Eva Moon, a writer, musician and performing artist, discusses her genetic mutation and how it changed the direction of her life.

Illuminating Ovarian Cancer

October 18th 2018

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience,” storytelling event hosted through a special engagement with The Moth.

Daily Aspirin Use Could Reduce Ovarian Cancer Risk and Improve Survival

October 14th 2018

New research indicates that aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) could not only reduce the risk of ovarian cancer, but also improve survival with daily use.

Know Your Family's Health History

October 12th 2018

After testing positive for the BRCA mutation, Pulaski has become an advocate and authored a book titled “Mom’s Genes,” which focuses on starting the conversation with children about their family’s health history.